Here’s Why This Obesity Drug Company’s Share Price Soared Today

The company had positive updates on its clinical trials.

In common with many other small-cap biotech stocks, Viking Therapeutics(VKTX +7.73%) share price tends to be volatile as investors react to the ebb and flow of news from the company. Today was an up day with the stock rising more than 10% by 12:30 p.m. ET.

Why Viking Therapeutics’ stock soared

The move comes on the day the company released its third-quarter earnings report and updated the market on the progress of its clinical trials.

Viking Therapeutics Stock Quote

Today’s Change

(7.73%) $2.43

Current Price

$33.85

The company’s lead drug candidate, VK2735 (obesity), is being…

Source link